Theravance Biopharma, Inc. (NASDAQ:TBPH) Q3 2025 Earnings Call Transcript November 10, 2025
Theravance Biopharma, Inc. beats earnings expectations. Reported EPS is $0.07, expectations were $-0.03.
Operator: Ladies and gentlemen, good afternoon. I’d like to welcome everyone to the Theravance Biopharma Third Quarter 2025 Conference Call. During the presentation, all participants session will follow the company’s formal remarks. To ask a question, please mute audio on your webcast device before...
